Instil Bio, Inc.
TIL
Rank in Stocks
#23279
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm,... Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research involves the advancement of autologous tumor-infiltrating lymphocyte (TIL) cell therapies. Their developmental portfolio features ITIL-168, currently under investigation for a range of malignancies including melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer. Another promising candidate, ITIL-306, is engineered to identify folate receptor alpha (FOLR1) and is being explored for gynecological cancers, non-small cell lung cancer, renal cancer, and other conditions. This company was founded in 2018 and has its principal office situated in Dallas, Texas.
Share Price
$6.47
Last synced: 2026-11-09
Market Cap
$43.88M
Change (1 day)
-5.27%
Change (1 year)
-58.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Instil Bio, Inc. (TIL)
Category
Healthcare
Operating Margin for Instil Bio, Inc. (TIL)
Operating Margin as of November 2026 TTM: 0.00%
According to Instil Bio, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Instil Bio, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -24,379.71% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Instil Bio, Inc.'s operating margin
What was Instil Bio, Inc.'s operating margin in 2025?
In 2025, Instil Bio, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Instil Bio, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Instil Bio, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-24,379.71%).
How does Instil Bio, Inc.'s operating margin compare with similar companies?
Instil Bio, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.